P. N Somthane
Kiran.H Makhija
Aarati Rajaram Sonawane
Ashwini Gavit
Dr. N.S. Vyawahare
- Assistant Professor Dr. D Y Patil College Of Pharmacy, Akurdi Maharashtra India
- Assistant Professor Dr. D Y Patil College Of Pharmacy, Akurdi Maharashtra India
- Assistant Professor Dr. D Y Patil College Of Pharmacy, Akurdi Maharashtra India
- Assistant Professor Dr. D Y Patil College Of Pharmacy, Akurdi Maharashtra India
- Principal Dr. D Y Patil College Of Pharmacy, Akurdi Maharashtra India
Abstract
Panic disorder is a prevalent mental health condition characterized by sudden, recurring episodes of intense fear accompanied by physical symptoms. It is twice as likely to affect women and may have a genetic predisposition. This disorder stems from an exaggerated response of the body’s survival mechanisms and hormones, impacting manifestations like agoraphobia. Additionally, it is associated with significant psychiatric comorbidity and impaired functioning in various roles. Recent research has delved into the neurobiology of common psychiatric disorders, particularly anxiety disorders, and their associated cognitive deficits. Studies have highlighted brain abnormalities in individuals experiencing fearful episodes, which can result in deficits in literacy and memory. The presence of anxiety and depression concurrently can further affect neuropsychological performance, although anxiety alone may not notably impact memory function. Understanding the interplay between anxiety, depression, and cognitive functioning is crucial for comprehensive treatment approaches in panic disorder and related conditions. This research sheds light on the complex mechanisms underlying these disorders and informs therapeutic interventions aimed at alleviating symptoms and improving overall quality of life.
Keywords: Anxiety disorders, Panic attack, Antidepressants , Neurophysiological. Obsessive-compulsive disorder.
[This article belongs to Research & Reviews: A Journal of Pharmaceutical Science(rrjops)]
Browse Figures
References
1. “Anxiety Disorders”. Mental Health Information: Health Topics. National Institute of Mental Health. March 2016. Archived from the original on 29 September 2016. Retrieved 1 October 2016. NIMH » Anxiety Disorders (archive.org)
2. American Psychiatric Association (2013), Diagnostic and Statistical Manual of Mental Disorders (5th ed.), Arlington: American Psychiatric Publishing, pp. 208–217, 938, ISBN 978-0890425558
3. “Panic Disorder: When Fear Overwhelms”. National Institute of Mental Health. 2013. Archived from the original on 4 October 2016. Retrieved 1 October 2016.
4. Craske MG, Stein MB (December 2016). “Anxiety”. Lancet. 388 (10063): 3048–3059. doi:10.1016/S0140-6736(16)30381-6. PMID 27349358. S2CID 208789585.
5. “F41.0 Panic disorder [episodic paroxysmal anxiety]”. The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines. World Health Organization. 2004 [1992]. p. 139. ISBN 92-4-154422-8.
6. Herr NR, Williams JW, Benjamin S, McDuffie J (July 2014). “Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review”. JAMA. 312 (1): 78–84. doi:10.1001/jama.2014.5950. PMID 25058220.
7. “Panic disorder”. UK National Heath Service. 16 February 2021.
8. Craske, Michelle G.; Kircanski, Katharina; Epstein, Alyssa; Wittchen, Hans-Ulrich; Pine, Danny S.; Lewis-Fernández, Roberto; Hinton, Devon (February 2010). “Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V”. Depression and Anxiety. 27 (2): 93–112. doi:10.1002/da.20654. PMID 20099270. S2CID 17789728.
9. Freire, Rafael C.; Perna, Giampaolo; Nardi, Antonio E. (July 2010). “Panic Disorder Respiratory Subtype: Psychopathology, Laboratory Challenge Tests, and Response to Treatment”. Harvard Review of Psychiatry. 18 (4): 220–229. doi:10.3109/10673229.2010.493744. PMID 20597592. S2CID 13567414.
10. Diler, Rasim Somer; Birmaher, Boris; Brent, David A.; Axelson, David A.; Firinciogullari, Sekip; Chiapetta, Laurel; Bridge, Jeff (2004). “Phenomenology of panic disorder in youth”. Depression and Anxiety. 20 (1): 39–43. doi:10.1002/da.20018. PMID 15368595. S2CID 23612310.
11. Jump up to:a b Frisch, N.; Frisch, L. (2006). Psychiatric Mental Health Nursing (3rd ed.). Canada: Thomson Delmar Learning. ISBN 9781401856441.[page needed]
12. Healy (2009) Psychiatric Drugs Explained
13. O’Mahony, J.F; Ward, B.G (2003). “Differences between those who panic by day and those who also panic by night”. Journal of Behavior Therapy and Experimental Psychiatry. 34 (3–4): 239–249. doi:10.1016/j.jbtep.2003.10.001. PMID 14972671.
14. “Anxiety”. Parkinson’s Foundation.
15. Jump up to:a b c Khalsa, Sahib S.; Lapidus, Rachel C. (2016). “Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?”. Frontiers in Psychiatry. 7: 121. doi:10.3389/fpsyt.2016.00121. PMC 4958623. PMID 27504098.
16. Comer, Ronald (2014). Fundamentals of Abnormal Psychology (7th ed.). New York: Worth Publishers. p. 122. ISBN 978-1-4292-9563-5.
17. Etkin A (2010). “Functional neuroanatomy of anxiety: a neural circuit perspective”. In Stein MB, Steckler T (eds.). Behavioral Neurobiology of Anxiety and Its Treatment. Current Topics in Behavioral Neurosciences. Vol. 2. pp. 251–77. doi:10.1007/7854_2009_5. ISBN 978-3-642-02911-0. PMID 21309113.
18. Clark, D.A.; Beck, A.T. (2011). The Anxiety and Worry Workbook: The Cognitive Behavioral Solution. Guilford Press. ISBN 9781606239186.
19. ^ Hawks E, Blumenthal H, Feldner MT, Leen-Feldner EW, Jones R (September 2011). “An examination of the relation between traumatic event exposure and panic-relevant biological challenge responding among adolescents”. Behavior Therapy. Elsevier Ltd. 42 (3): 427–38. doi:10.1016/j.beth.2010.11.002. PMID 21658525.
20. “Panic Disorder and Pharmacological Treatment Options”. Archived from the original on 15 April 2012. Retrieved 12 May 2012.
21. Flory, J. D.; Yehuda, R. (2015). “Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations”. Dialogues in Clinical Neuroscience. 17 (2): 141–150. doi:10.31887/DCNS.2015.17.2/jflory. PMC 4518698. PMID 26246789.
22. Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K (January 2005). “Information-processing deficits and cognitive dysfunction in panic disorder”. Journal of Psychiatry & Neuroscience. 30 (1): 37–43. PMC 543839. PMID 15644996.
23. Katerndahl DA, Realini JP (1999). “Relationship between substance abuse and panic attacks”. Addictive Behaviors. 24 (5): 731–6. doi:10.1016/s0306-4603(98)00078-1. PMID 10574314.
24. Akindipe T, Wilson D, Stein DJ (June 2014). “Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors”. Metabolic Brain Disease. 29 (2): 351–7. doi:10.1007/s11011-014-9496-5. PMID 24532047. S2CID 14880172.
25. https://www.google.co.in/search?q=panic+disroder+defination&sca_esv=590880697&ei=Xfiz-serp
Research & Reviews: A Journal of Pharmaceutical Science
| Volume | 15 |
| Issue | 01 |
| Received | January 18, 2024 |
| Accepted | February 16, 2024 |
| Published | March 30, 2024 |
